Chargement en cours...
Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
Choosing antithrombotic regimens for patients with atrial fibrillation (AF) who underwent percutaneous coronary intervention (PCI) with stent placement is challenging. Until recently, the guidelines recommended warfarin-based triple therapy, which causes frequent major bleeding events in up to 12% o...
Enregistré dans:
| Publié dans: | J Lipid Atheroscler |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Society of Lipidology and Atherosclerosis
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7379079/ https://ncbi.nlm.nih.gov/pubmed/32821695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12997/jla.2019.8.1.8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|